|Videos|December 29, 2022
Healthcare Team Members Involved in Treating Myeloproliferative Neoplasms
Author(s)Ruben Mesa, M.D., Rami S. Komrokji, M.D.
Comprehensive insight on the various healthcare team members a hematologist-oncologist may work with to optimize care of myeloproliferative neoplasms.
Advertisement
Episodes in this series
Advertisement
Related to this article
Phase 2 findings on divesiran point to a potential way to control hematocrit while reducing repeated blood draws for those living with polycythemia vera, like Nona Baker.
Advertisement
Advertisement
Trending on CURE
1
Blood Cancer Treatments in the FDA Pipeline: What Could Come Next
2
3 More Lung Cancer Breakthroughs From WCLC 2026
3
FDA Approves Inluriyo Plus Verzenio for Certain Advanced Breast Cancers
4
Myeloma Guidelines Call for Yearly Measurable Residual Disease Testing
5